GPBA receptor (gpbar_rat)

FAMILY

Class A (Rhodopsin) Steroid receptors Bile acid receptors GPBA receptor

GENE

Gpbar1 (Tgr5)

ORGANISM

Rat (Rattus norvegicus)

ALT. NAMES

G-protein coupled bile acid receptor 1, Membrane-type receptor for bile acids, M-BAR

SOURCE

SWISSPROT

SEQUENCE

N-term        
M
M
S
H
N
T
T
E
L
S
10
    TM1          
A
I
P
R
G
V
Q
E
L
S
20
                   
L
V
L
A
S
L
I
V
I
A
30
                   
N
L
L
L
A
L
G
I
V
L
40
  ICL1 TM2    
D
R
H
L
R
S
P
P
A
G
50
                   
C
F
F
L
S
L
L
L
A
G
60
                   
L
L
T
G
L
A
L
P
T
L
70
      ECL1      
P
G
L
W
N
R
S
H
Q
G
80
TM3              
Y
W
S
C
L
L
L
H
L
A
90
                   
P
N
F
C
F
L
S
L
L
A
100
                   
N
L
L
L
V
H
G
E
R
Y
110
          ICL2  
M
A
V
L
Q
P
L
R
P
H
120
  TM4            
G
S
V
R
L
A
L
F
L
T
130
                   
W
I
S
S
L
L
F
A
S
L
140
        ECL2    
P
A
L
G
W
N
H
W
S
P
150
                   
G
A
N
C
S
S
Q
A
I
F
160
TM5              
P
A
P
Y
L
Y
L
E
V
Y
170
                   
G
L
L
L
P
A
V
G
A
T
180
                   
A
L
L
S
V
R
V
L
A
T
190
                   
A
H
H
Q
L
R
E
I
R
R
200
            ICL3
L
E
R
A
V
C
R
D
A
P
210
TM6              
S
T
L
A
R
A
L
T
W
R
220
                   
Q
A
R
A
Q
A
G
A
T
L
230
                   
L
F
L
L
C
W
G
P
Y
V
240
                   
A
T
L
L
L
S
V
L
A
Y
250
    ECL3 TM7  
E
R
R
P
P
L
G
P
V
T
260
                   
L
L
S
L
I
S
L
G
S
A
270
                   
S
A
A
V
V
P
V
A
M
G
280
    H8            
L
G
D
Q
R
Y
T
A
P
W
290
                   
R
T
A
A
Q
R
W
L
Q
V
300
C-term        
L
R
G
R
P
K
R
A
N
P
310
                   
G
P
S
T
A
Y
H
S
S
S
320
                 
Q
C
S
T
D
L
D
L
N

LINKS

DIAGRAMS

ICL1 R H L R ICL1ECL1 W N R S H Q ECL1ICL2 P L R P H G ICL2ECL2 W N H W S P G A N C S S Q A I F ECL2ICL3 R D A P ICL3ECL3 R P P L ECL3N-term M M S H N T T E L S A I N-termC-term R W L Q V L R G R P K R A N P G P S T A Y H S S S Q C S T D L D L N C-term P R G V Q E L S L V L A S L I V I A N L L L A L G I V L D S P P A G C F F L S L L L A G L L T G L A L P T L P G L G Y W S C L L L H L A P N F C F L S L L A N L L L V H G E R Y M A V L Q S V R L A L F L T W I S S L L F A S L P A L G P A P Y L Y L E V Y G L L L P A V G A T A L L S V R V L A T A H H Q L R E I R R L E R A V C S T L A R A L T W R Q A R A Q A G A T L L F L L C W G P Y V A T L L L S V L A Y E R G P V T L L S L I S L G S A S A A V V P V A M G L G D Q R W R T Y T A P A A Q
Pick color:
 
 
 
 
 
 
 
 
 
 
 
 




Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A

L N A I V I L S A L V L S L E Q V G R P 1 L S L L L A G L L T G L A L P T L P G L 2 L L L N A L L S L F C F N P A L H L L L 3 V R L A L F L T W I S S L L F A S L P A 4 S L L A T A G V A P L L L G Y V E L Y L Y 5 A G A T L L F L L C W G P Y V A T L L L 6 V P V V A A S A S G L S I L S L L T V 7
Pick color:
 
 
 
 
 
 
 
 
 
 
 
 




Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A

MUTATIONS

ENDOGENOUS LIGANDS

No endogenous ligands available

STRUCTURE MODELS

No structure models available. Check the Archive on Structure models for earlier releases.

STRUCTURES

No structures available